Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Rectal Cancer | Case report

Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report

Authors: Shinya Taguchi, Yoshiki Koshikawa, Shoya Ohyama, Hiroko Miyachi, Hiroaki Ozawa, Hiroaki Asada

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Thrombospondin type-1 domain-containing 7A (THSD7A) is a target antigen in idiopathic membranous nephropathy (MN). Patients with THSD7A-associated MN are known to have a high possibility of developing malignancy. However, there are few case reports on THSD7A-associated MN with malignancy, and details of its characteristics have not been clarified thoroughly. Here, we report the case of a 77-year-old male patient who was diagnosed with THSD7A-associated MN after resection of rectal cancer.

Case presentation

A 77-year-old man who had developed bilateral peripheral edema, persistent proteinuria, and nephrotic syndrome was admitted to our hospital. He was diagnosed with MN based on a renal biopsy 3 years after resection of rectal cancer, and positive staining for THSD7A in both kidney and rectal cancer tissues suggested that these two diseases were related. Furthermore, THSD7A staining of metastatic lymph nodes revealed deposition of THSD7A in the secondary lymph follicles and sinus. Recurrence of rectal cancer was suspected; however, tumor recurrence was not observed on chest and abdominal computed tomography (CT) and colonoscopy. There was no lymph node enlargement. The patient was kept on observation with supportive therapy. Consequently, although nephrotic syndrome persisted, obvious recurrence and metastasis of the primary tumor were not observed.

Conclusion

This is the first case in which pathological examination results suggested that THSD7A-associated MN was caused by rectal cancer. Based on the reports of THSD7A-associated MN with malignancy and the pathogenesis of MN, lymph node metastasis may be a risk for cancer-related MN.
Literature
1.
go back to reference Cattran DC, Kim ED, Reich H, Hladunewich M, Kim SJ. Toronto glomerulonephritis registry group and for the TGR. Membranous nephropathy: quantifying remission duration on outcome. J Am Soc Nephrol. 2017;28:995–1003.CrossRef Cattran DC, Kim ED, Reich H, Hladunewich M, Kim SJ. Toronto glomerulonephritis registry group and for the TGR. Membranous nephropathy: quantifying remission duration on outcome. J Am Soc Nephrol. 2017;28:995–1003.CrossRef
2.
go back to reference Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol. 2014;9:609–16.CrossRef Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol. 2014;9:609–16.CrossRef
3.
go back to reference Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.CrossRef Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.CrossRef
4.
go back to reference Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371:2277–87.CrossRef Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371:2277–87.CrossRef
5.
go back to reference Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26:2526–32.CrossRef Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26:2526–32.CrossRef
6.
go back to reference Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RAK. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol. 2014;9:1883–90.CrossRef Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RAK. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol. 2014;9:1883–90.CrossRef
7.
go back to reference Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6:1286–91.CrossRef Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6:1286–91.CrossRef
8.
go back to reference Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al. A mechanism for Cancer-associated membranous nephropathy. N Engl J Med. 2016;374:1995–6.CrossRef Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al. A mechanism for Cancer-associated membranous nephropathy. N Engl J Med. 2016;374:1995–6.CrossRef
9.
go back to reference Hoxha E, Beck LH, Wiech T, Tomas NM, Probst C, Mindorf S, et al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol. 2017;28:520–31.CrossRef Hoxha E, Beck LH, Wiech T, Tomas NM, Probst C, Mindorf S, et al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol. 2017;28:520–31.CrossRef
10.
go back to reference LEE JC, YAMAUCHI H, HOPPER J. The Association of Cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41–51.CrossRef LEE JC, YAMAUCHI H, HOPPER J. The Association of Cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41–51.CrossRef
11.
go back to reference Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40:29–35.CrossRef Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40:29–35.CrossRef
12.
go back to reference Stahl PR, Hoxha E, Wiech T, Schröder C, Simon R, Stahl RAK. THSD7A expression in human cancer. Genes Chromosom Cancer. 2017;56:314–27.CrossRef Stahl PR, Hoxha E, Wiech T, Schröder C, Simon R, Stahl RAK. THSD7A expression in human cancer. Genes Chromosom Cancer. 2017;56:314–27.CrossRef
13.
go back to reference Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol. 2003;23:400–5.CrossRef Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol. 2003;23:400–5.CrossRef
14.
go back to reference Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79:5557–61.CrossRef Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79:5557–61.CrossRef
15.
go back to reference Kerjaschki D. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN). Kidney Blood Press Res. 2000;23:163–6.PubMed Kerjaschki D. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN). Kidney Blood Press Res. 2000;23:163–6.PubMed
16.
go back to reference Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann J-P, Bensman A, et al. Antenatal membranous glomerulonephritis due to anti–neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053–60.CrossRef Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann J-P, Bensman A, et al. Antenatal membranous glomerulonephritis due to anti–neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053–60.CrossRef
17.
go back to reference Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H. Prevalence of enhanced granular expression of thrombospondin Type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS One. 2015;10:e0138841.CrossRef Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H. Prevalence of enhanced granular expression of thrombospondin Type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS One. 2015;10:e0138841.CrossRef
18.
go back to reference Wang J, Cui Z, Lu J, Probst C, Zhang Y, Wang X, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2017;12:1642–51.CrossRef Wang J, Cui Z, Lu J, Probst C, Zhang Y, Wang X, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2017;12:1642–51.CrossRef
19.
go back to reference Wang C-H, Su P-T, Du X-Y, Kuo M-W, Lin C-Y, Yang C-C, et al. Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J Cell Physiol. 2009;222:685–94. Wang C-H, Su P-T, Du X-Y, Kuo M-W, Lin C-Y, Yang C-C, et al. Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J Cell Physiol. 2009;222:685–94.
20.
go back to reference Kuo M-W, Wang C-H, Wu H-C, Chang S-J, Chuang Y-J. Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis. PLoS One. 2011;6:e29000.CrossRef Kuo M-W, Wang C-H, Wu H-C, Chang S-J, Chuang Y-J. Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis. PLoS One. 2011;6:e29000.CrossRef
21.
go back to reference Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417–23. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417–23.
22.
go back to reference Yoon H, Dehart JP, Murphy JM, S-TS L. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. J Histochem Cytochem. 2015;63:114–28.CrossRef Yoon H, Dehart JP, Murphy JM, S-TS L. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. J Histochem Cytochem. 2015;63:114–28.CrossRef
23.
go back to reference Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int. 1980;17:1–13.CrossRef Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int. 1980;17:1–13.CrossRef
24.
go back to reference Beck LH. Membranous nephropathy and malignancy. Semin Nephrol. 2010;30:635–44.CrossRef Beck LH. Membranous nephropathy and malignancy. Semin Nephrol. 2010;30:635–44.CrossRef
25.
go back to reference Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22:1137–43.CrossRef Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22:1137–43.CrossRef
26.
go back to reference Qu Z, Liu G, Li J, Wu L -h, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27:1931–7.CrossRef Qu Z, Liu G, Li J, Wu L -h, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27:1931–7.CrossRef
27.
go back to reference Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–9.CrossRef Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–9.CrossRef
28.
go back to reference Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355–77.CrossRef Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355–77.CrossRef
Metadata
Title
Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report
Authors
Shinya Taguchi
Yoshiki Koshikawa
Shoya Ohyama
Hiroko Miyachi
Hiroaki Ozawa
Hiroaki Asada
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1236-y

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue